MRK vs RMD
By Alex · Tickerpine
Merck & Co., Inc. vs ResMed Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | RMD |
|---|---|---|
| Price | $145.27 | $252.86 |
| Market cap | $358.41B | $35.56B |
| P/E ratio | 117.2 | 24.2 |
| ROE | 6.96% | 24.27% |
| Profit margin | 4.77% | 26.95% |
| Revenue growth | 5.10% | 8.60% |
| Dividend yield | 2.34% | 1.04% |
| Beta | 0.22 | 0.75 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs RMD in plain English
- MRK is the bigger company — about 10.1× the market cap of RMD.
- RMD is cheaper on earnings (P/E 24.2 vs 117.2).
- RMD earns a higher return on equity (24% vs 7%).
- RMD is growing revenue faster (9% vs 5%).
- MRK has the higher dividend yield (2.34% vs 1.04%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
RMD return calculator
See what $1,000 in ResMed Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.